Goldstein; Glenn A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goldstein; Glenn A..The latest application filed is for "use of n-acetylcysteine amide in the treatment of acquired immune deficiency syndrome and hiv infection".

Company Profile

10.11.31

Goldstein; Glenn A. - New York NY US
Goldstein; Glenn A. - Brooklyn NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress Grant 10,869,846 - Goldstein December 22, 2	2020-12-22
Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection App 20200170968 - GOLDSTEIN; GLENN A.	2020-06-04
Use Of N-acetylcysteine Amide In The Treatment Of Acetaminophen Overdose App 20200069617 - Goldstein; Glenn A.	2020-03-05
Use Of N-acetylcysteine Amide In The Treatment Of Penetrating Head Injury App 20200038349 - Goldstein; Glenn A.	2020-02-06
Use of N-acetylcysteine Amide in the Treatment Of Disease and Injury App 20190388369 - Goldstein; Glenn A.	2019-12-26
Use Of N-acetylcysteine Amide For Decreasing Intracranial Pressure App 20190151262 - GOLDSTEIN; GLENN A.	2019-05-23
N-acetylcysteine Amide (nac Amide) In The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20190111009 - Goldstein; Glenn A.	2019-04-18
N-acetylcysteine Amide (nac Amide) In The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20170135970 - Goldstein; Glenn A.	2017-05-18
Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection App 20170049727 - Goldstein; Glenn A.	2017-02-23
Use Of N-acetylcysteine Amide In The Treatment Of Acetaminophen Overdose App 20170000747 - Goldstein; Glenn A.	2017-01-05
N-acetylcysteine Amide (nac Amide) In The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20160206576 - Goldstein; Glenn A.	2016-07-21
N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress Grant 9,216,162 - Goldstein December 22, 2	2015-12-22
N-acetylcysteine Amide (nac Amide) In The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20150164830 - Goldstein; Glenn A.	2015-06-18
Use Of N-acetylcysteine Amide In The Treatment Of Disease And Injury App 20150148423 - Goldstein; Glenn A.	2015-05-28
Use Of N-acetylcysteine Amide For Decreasing Intracranial Pressure App 20150133558 - Goldstein; Glenn A.	2015-05-14
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress Grant 8,993,627 - Goldstein March 31, 2	2015-03-31
Use Of N-acetylcysteine Amide In The Treatment Of Penetrating Head Injury App 20150038586 - Goldstein; Glenn A.	2015-02-05
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress Grant 8,937,099 - Goldstein January 20, 2	2015-01-20
N-acetylcysteine Amide (nac Amide) For The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20140187640 - Goldstein; Glenn A.	2014-07-03
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress Grant 8,354,449 - Goldstein January 15, 2	2013-01-15
N-acetylcysteine Amide (nac Amide) For Treatment Of Oxidative Stress Associated With Infertility App 20100137676 - Goldstein; Glenn A.	2010-06-03
N-acetylcysteine Amide (nac Amide) For The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20100137441 - Goldstein; Glenn A.	2010-06-03
N-acetylcysteine Amide (nac Amide) For The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20100120920 - Goldstein; Glenn A.	2010-05-13
N-acetylcysteine Amide (nac Amide) For The Treatment Of Diseases And Conditions Associated With Oxidative Stress App 20090234011 - Goldstein; Glenn A.	2009-09-17
N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental Stress App 20080274888 - Goldstein; Glenn A.	2008-11-06
N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with Infertility App 20080200548 - Goldstein; Glenn A.	2008-08-21
Ergonomic adjustable chair and method Grant 5,240,308 - Goldstein , et al. August 31, 1	1993-08-31
Ergonomic adjustable chair and method Grant 5,018,786 - Goldstein , et al. May 28, 1	1991-05-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.